The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

A multivariate analysis of prognostic factors from assure (E2805): Adjuvant sorafenib or sunitinib for unfavorable renal carcinoma.

Naomi B.  Haas

Stock and Other Ownership Interests  - TetraLogic Pharmaceuticals (I)

Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Merck

Expert Testimony - Lilly (I)

Judith  Manola

No Relationships to Disclose

Robert G.  Uzzo

Honoraria - GlaxoSmithKline; Johnson & Johnson

Consulting or Advisory Role - Myriad Genetics

Speakers' Bureau - Janssen Oncology

Keith  Flaherty

No Relationships to Disclose

Michael  Pins

Speakers' Bureau - Genentech/Roche; Pfizer

Edward M.  Messing

No Relationships to Disclose

Robert S.  DiPaola

Research Funding - Abbvie (Inst)